Shiraz E-Medical Journal

Published by: Kowsar

Predictors of Tuberculosis in HIV/AIDS Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran

Salman Khazaei 1 , Leila Molaeipoor 2 , Shahab Rezaeian 3 , Erfan Ayubi 4 , 5 , Mehran Yari 6 , * , Ali Asghar Valipour 6 and Somayeh Khazaei 7
Authors Information
1 Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Epidemiology, Pasteur Institute of Iran, Tehran, Iran
3 Social Determinant of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
6 Student Research Committee, Abadan School of Medical Sciences, Abadan, Iran
7 Department of Operating Room, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
Article information
  • Shiraz E-Medical Journal: October 01, 2016, 17 (10); e41542
  • Published Online: October 26, 2016
  • Article Type: Research Article
  • Received: August 15, 2016
  • Revised: October 9, 2016
  • Accepted: October 24, 2016
  • DOI: 10.17795/semj41542

To Cite: Khazaei S, Molaeipoor L, Rezaeian S, Ayubi E, Yari M, et al. Predictors of Tuberculosis in HIV/AIDS Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran, Shiraz E-Med J. 2016 ; 17(10):e41542. doi: 10.17795/semj41542.

Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. AIDS by the numbers 2015. 2015;
  • 2. Tuberculosis and HIV, 2015. 2015;
  • 3. Fact sheet 2015. 2015;
  • 4. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005; 5(10): 819-26[DOI][PubMed]
  • 5. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006; 367(9514): 926-37[DOI][PubMed]
  • 6. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, Lawn SD, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007; 175(1): 87-93[DOI][PubMed]
  • 7. Young DB, Perkins MD, Duncan K, Barry C3. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest. 2008; 118(4): 1255-65[DOI][PubMed]
  • 8. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009; 23(13): 1717-25[DOI][PubMed]
  • 9. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006; 20(12): 1605-12[DOI][PubMed]
  • 10. Radfar S, Taheri K, Namdari Tabar H. Practical guidelines on how to provide consulting services in behavioral disorders centers 2009;
  • 11. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007;
  • 12. Policy Statement on Preventive Therapy Against Tuberculosis in People Living with HIV. 2005;
  • 13. Tuberculosis report global. 2012;
  • 14. Tuberculosis (TB). 2016;
  • 15. Li N, Wang Z, Sun D, Zhu Q, Sun G, Yang W, et al. HIV among plasma donors and other high-risk groups in Henan, China. J Acquir Immune Defic Syndr. 2010; 53 Suppl 1: 41-7[DOI][PubMed]
  • 16. Xu J, Tang W, Cheng S, Mahapatra T, Zhou L, Lai Y, et al. Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS One. 2014; 9(2): 89723[DOI][PubMed]
  • 17. Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med. 2006; 52(2): 92-6[PubMed]
  • 18. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009; 49(4): 1335-74[DOI][PubMed]
  • 19. Schiavini M, Angeli E, Mainini A, Zerbi P, Duca PG, Gubertini G, et al. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002. HIV Med. 2006; 7(5): 331-7[DOI][PubMed]
  • 20. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002; 288(2): 199-206[PubMed]
  • 21. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007; 7(6): 402-9[DOI][PubMed]
  • 22. Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One. 2010; 5(5): 10527[DOI][PubMed]
  • 23. Martin-Echevarria E, Serrano-Villar S, Sainz T, Moreno A, Casado JL, Dronda F, et al. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy. Int J Tuberc Lung Dis. 2014; 18(9): 1080-4[DOI][PubMed]
  • 24. Molaeipoor L, Poorolajal J, Mohraz M, Esmailnasab N. Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study. Epidemiol Health. 2014; 36: 2014024[DOI][PubMed]
  • 25. Mirzaei M, Poorolajal J, Khazaei S, Saatchi M. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011). Int J STD AIDS. 2013; 24(11): 859-66[DOI][PubMed]
  • 26. Poorolajal J, Molaeipoor L, Mohraz M, Mahjub H, Ardekani MT, Mirzapour P, et al. Predictors of progression to AIDS and mortality post-HIV infection: a long-term retrospective cohort study. AIDS Care. 2015; 27(10): 1205-12[DOI][PubMed]
  • 27. Crump JA, Wu X, Kendall MA, Ive PD, Kumwenda JJ, Grinsztejn B, et al. Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study. BMC Infect Dis. 2015; 15: 12[DOI][PubMed]
  • 28. Fenner L, Forster M, Boulle A, Phiri S, Braitstein P, Lewden C, et al. Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis. 2011; 15(5): 620-7[DOI][PubMed]
  • 29. Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, et al. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis. 2015; 15: 62[DOI][PubMed]
  • 30. Ting WY, Huang SF, Lee MC, Lin YY, Lee YC, Feng JY, et al. Gender disparities in latent tuberculosis infection in high-risk individuals: a cross-sectional study. PLoS One. 2014; 9(11): 110104[DOI][PubMed]
  • 31. Hassanzadeh J, Moradi N, Esmailnasab N, Rezaeian S, Bagheri P, Armanmehr V. The Correlation between Gender Inequalities and Their Health Related Factors in World Countries: A Global Cross-Sectional Study. Epidemiol Res Inte. 2014; 2014(2014): 1-8[DOI]
  • 32. Zumla A, Atun R, Maeurer M, Kim PS, Jean-Philippe P, Hafner R. Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. J Infect Dis. 2012; 205(2): 141-6[DOI]
  • 33. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, et al. Tuberculosis and HIV control in sub-Saharan African prisons: "thinking outside the prison cell". J Infect Dis. 2012; 205 Suppl 2: 265-73[DOI][PubMed]
  • 34. Henostroza G, Topp SM, Hatwiinda S, Maggard KR, Phiri W, Harris JB, et al. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PLoS One. 2013; 8(8): 67338[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments